1. India Stocks

  2. •

    Financial Services

  3. •

    Financial - Conglomerates
Amerise Biosciences Ltd.

Amerise Biosciences Ltd.

AMERISE.BO
Amerise Biosciences Ltd.IN flagBombay Stock Exchange
0.81
INR
- -
- -
53.52MMarket Cap

Total Valuation

Amerise Biosciences Ltd. carries a market capitalization of 53.52M, placing it among publicly traded companies globally. Its enterprise value stands at 32.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap53.52M
Enterprise Value32.36M

Share Statistics

Amerise Biosciences Ltd. currently has 66.07M shares outstanding.

Shares Outstanding66.07M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Amerise Biosciences Ltd. trades at a trailing price-to-earnings ratio of 185.81.

PE Ratio185.81
PS RatioN/A
PB Ratio0.58
P/TBV Ratio0.71
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

EV / SalesN/A
EV / EBITDA115.38
EV / EBIT115.38
EV / FCFN/A

Financial Position

Amerise Biosciences Ltd. maintains a current ratio of 0.30, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

Current Ratio0.30
Quick Ratio0.29
Debt / EquityN/A
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

Amerise Biosciences Ltd. posts a return on equity of 0.35 and a return on invested capital of -1.70.

Return on Equity (ROE)0.35
Return on Assets (ROA)0.26
Return on Invested Capital (ROIC)-1.70
Return on Capital Employed (ROCE)0.35
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Amerise Biosciences Ltd.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.75, while the 200-day moving average is 0.67.

Beta (5Y)N/A
52-Week Price Change0%
50-Day Moving Average0.75
200-Day Moving Average0.67
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -918,000.00, while operating income came in at -918,000.00.

RevenueN/A
Gross Profit-737,000.00
Operating Income-918,000.00
Pretax Income206,000.00
Net Income206,000.00
EBITDA-918,000.00
EBIT-918,000.00
Earnings Per Share (EPS)0.00

Balance Sheet

Total book value stands at 66.07M, with working capital of -14.14M providing operational flexibility.

Cash & Cash Equivalents5.92M
Total DebtN/A
Net Debt-177,000.00
Equity (Book Value)66.07M
Book Value Per Share1.02
Working Capital-14.14M

Scores

Amerise Biosciences Ltd. posts an Altman Z-Score of 0.86, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.86